I"1<div class="row justify-content-between">
<div class="col-md-8 pr-5 about-us">

<h3>Why TomorrowScale?</h3>

<p>To tackle the biggest problems, and to build the best science-based companies, we must explore more stories from the scientists and entrepreneurs on the benches and in the trenches of R&amp;D. Iâ€™m a scientist and entrepreneur who is here because of a passion for scientific discovery and a desire to learn directly from peers and leaders regardless of geography.</p>

<blockquote>These are stories from the cutting edge.</blockquote>

<h4>Creator &amp; Host</h4>

<p><a target="_blank" href="https://linkedin.com/in/briggsly">Justin Briggs</a> is the host of the TomorrowScale Podcast. Justin is a biotechnology executive and deep technology entrepreneur who works at the nexus of chemistry, biology, and engineering.</p>

<p>Currently, Justin serves as Senior Director of Drug Development and Program Management at Tetherex Pharmaceuticals. Tetherex is a clinical-stage biopharmaceutical company developing SelK2 (anti-PSGL-1), a monoclonal antibody for the treatment of multiple inflammatory conditions.</p>

<p>Justin has been involved as a founder, investor, advisor, or team member for more than a dozen biotech, nanotech, robotics, and software companies, and gained experience across a wide range of development and commercialization activities relevant to early-stage science-based companies.</p>

<p>Prior to Tetherex, Justin worked on both sides of the table at a biotech venture accelerator and venture capital fund, serving as Vice President of Business Development and Operations at Accele BioPharma and Venture Associate at Accele Venture Partners. Accele identified, funded, and managed novel therapeutic and diagnostic startups, including programs to regenerate beta cells in the pancreas for diabetes, regenerate neurons and hair cells for hearing loss and balance disorders, discovery of fully human antibodies for cancer, infectious, and neglected disease treatments and diagnostics, and antibiotics discovery tackling multi-drug resistant organisms. Justin also founded SnapLap Technologies (machine vision AI for energy exploration) and Chorus Labs (productivity software) and is an inventor and author on multiple patents and peer-reviewed publications.</p>

<p>In 2019, based on a passion for difficult scientific problems and the companies that tackle them, Justin created TomorrowScale. The TomorrowScale podcast is a series of conversations with the scientists and entrepreneurs who are building the future.</p>

<h4>Questions or Story Ideas? </h4>

<p>Any research or startups we should ear about? Send us an <a href="mailto:justin@tomorrowscale.com?subject=TomorrowScale Inquiry">email</a>.</p>

</div>

<div class="col-md-4">

<div class="sticky-top sticky-top-80">
<h5>Support TomorrowScale</h5>

<p>Thank you for your support! Your help supports producing, maintaining, and improving TomorrowScale and the <a target="_blank" href="https://anchor.fm/tomorrowscale">The TomorrowScale Podcast</a>.</p>

<br /><br />

<a target="_blank" href="https://www.patreon.com/tomorrowscale?utm_content=author_sidebar_widget&amp;utm_medium=patron_button_and_widgets_plugin&amp;utm_campaign=3917030&amp;utm_term=&amp;utm_source=https://www.tomorrowscale.com/about/" class="btn btn-warning">Become a Patron</a> 

<br /><br />

</div>
</div>
</div>
:ET